Global Parasitology Identification Market Size, Trends and Growth Opportunity, By Products (Consumables and Accessories, Devices), By Methods (Microscopic Identification, Fecal Identification, Immunological Techniques, Morphological Identification, Molecular Techniques, Rapid Diagnostic Tests (RDTs), Maldi-TOF MS, Others), By Pathogen Type (Protozoan, Helminths, Arthropodes, Tapeworm, Ectoparast), By Sample (Feces, Blood, Urine, Cerebrospinal Fluid (CSF), Serum and Plasma, Others), By Stool Concentration and Preparation (Concentration Technique, Un-Concentration Technique), By End User (Diagnostic Centers, Hospitals, Clinics, Ambulatory Surgical Centres, Others), By Region and Forecast till 2030.
Global Parasitology Identification Market
Global Parasitology Identification Market was valued at USD 4,092.17 million in 2022 and is slated to reach at USD 6,522.29 million by 2030 at a CAGR of 6.5% from 2023-2030.
Parasitology is the study of parasites, their hosts, and their interactions. One creature, the parasite, benefits at the expense of another, the host, which is often an organism of a different species, in the symbiotic relationship known as parasitism. The host may also suffer negative effects from the connection. As a branch of biology, parasitology focuses on how parasites live rather than the organism or environment being studied. Cell biology, bioinformatics, biochemistry, molecular biology, immunology, genetics, evolution, and ecology are just a few of the scientific fields that it synthesises knowledge from across and includes methods from.
Market Drivers
The development in strategic endeavours by companies throughout the world to improve healthcare systems has increased the need for the parasitology identification market in both developed and developing nations. Rising disposable income, parasitology identification, and quick diagnostic techniques for identifying and treating infectious and parasitic disorders are all factors in the expansion of the parasitology identification industry. The strategic initiative to promote parasitology identification and explore untapped markets will cause the market to expand during the predicted time frame. A parasite must be isolated, then cultured, expanded, and subjected to further sequence testing in order to be diagnosed. The prevalence of illnesses caused by numerous pathogen types, such as protozoans, helminths, and ectoparasites, raises serious concerns regarding the need for cutting-edge technologies for identifying parasitic strains. To detect parasite strains, many standard approaches have been used for years. Modern, more accurate, more sensitive techniques have also been applied in diagnostic labs. The market is further stimulated by the use of cutting-edge methods like MALDI-TOF MS, Rapid Diagnostic assays, and others for an accurate and speedy detection of the parasitic strain.
Market Restraints
Methods of identification based on molecules are precise, sensitive, and vulnerable. In addition, there are several major problems with molecular techniques, including the high cost of the devices, RT PCR, and MALDI-TOF. The usefulness in developing nations is restricted, and the creation of expensive detecting instruments is confined. The market for parasite identification is growing as a result of factors like the rise in chronic infectious diseases, heightened government participation, and the application of machine learning and artificial intelligence for parasite detection and diagnosis. The market expansion throughout the projected period may be hampered by higher diagnostic costs and erroneous data interpretation. A microscope is typically used in parasite identification procedures. When examined under a microscope, parasites can be detected in samples of blood smears, faeces, lymph node aspirates, tissues, or cerebrospinal fluid; however, the labour- and time-intensive nature of sample preparation for viewing under a microscope limits the field's potential for advancement.
Recent Development
Abbott conducted a malaria study in the Mpigi district in 2020 using their most recent fast diagnostic malaria kit and the industry-standard test. With a doubled positivity rate in comparison to the conventional test, Abbott's rapid diagnostic test produced some ground-breaking results. As a result, the company's brand value has increased in the marketplace.
BD's automated flow cytometer, the BD FACSDUET, was given the all-clear in 2020. Automation solutions for flow cytometry, such as the BD FACSDuetTM and BD FACSLyricTM Complete Sample-to-Answer Solution, contribute to increased throughput and consistent results that clinicians can rely on to direct patient care by improving accuracy and standardisation from instrument to instrument and operator to operator.
Market Segmentation
Global Parasitology Identification Market is segmented into Products, Methods, Pathogen Type, Sample, Stool Concentration and Preparation, and End-User. By Products such as Consumables and Accessories, Devices, Polymerase Chain Reaction (PCR), Madd Spectrometers, Microscopes, Polystrainers, Flow Cytometers, Others. By Methods such as Microscopic ideantification, Fecal Identification, Immunological Techniques, Enzyme linked immunosorbent Assay (ELISA), Heamaggulutination Assay, Others, Morphological Identification, Molecular Techniques, Rapid Diagnostic Tests (RDTs), Maldi-TOF MS, Others. By Pathogen Type such as Protozoan, Helminths, Arthropodes, Tapeworm, Ectoparast. By Sample Feces, Blood, Urine, Cerebrospinal fluid (CSF), Serum and Plasma, Others. By Stool Concentration and Preparation such as Concentration Technique, Un-Concentration Technique. By End-Users such as Diagnostic Centers, Hospitals, Clinics, Ambulatory surgical centers, Others.
Regional Analysis
Global Parasitology Identification Market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The market is dominated by North America, and this trend of dominance will flourish during the projection period. The greatest consumer market and the region's high gross domestic product are the main causes of its dominance. Due to factors such as increasing healthcare costs, increased parasitology-related research and development, and trending diagnostic tool advancements, the U.S., which currently dominates the parasitology identification market in North America, is anticipated to grow at a CAGR over the course of the forecast period. Because of advancements in medical infrastructure-driven parasitology detection and federal bodies' activities, Asia-Pacific will experience the highest growth rate during the forecast period. In the Asia-Pacific market, China is likely to dominate. China is a world leader in parasitology identification, with fast expanding product utilisation.
Key Players
This report includes a list of numerous Key Players, namely Abbott (U.S.), BD (U.S.), bioMérieux, Inc. (France), Bruker (U.S.), Quest Diagnostics (U.S.), Akron Biotech (U.S.), Thermo Fisher Scientific Inc (U.S.), altona Diagnostics GmbH (Germany), Biomerica (U.S.), Bio-Rad Laboratories, Inc. (U.S.).
Market Taxonomy
By Products
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook